The importance of the enzyme Gamma-glutamyltransferase in the pathogenic cluster in type2 diabetic patient

1. RADHAKRISHNAN P, SRIKANTH P, SESHADRI KG, BARANI R, SAMANTA M. Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis. Indian journal of endocrinology and metabolism. 2014;18(4):505. Search in Google Scholar

2 ZHAO W, TONG J, LIU J, LIU J, LI J, CAO Y. The dose-response relationship between gamma-glutamyl transferase and risk of diabetes mellitus using publicly available data: a longitudinal study in Japan. International journal of endocrinology. 2020. Search in Google Scholar

3 KOENIG G, SENEFF S. Gamma-glutamyltransferase: a predictive biomarker of cellular antioxidant inadequacy and disease risk. Disease markers. 2015. Search in Google Scholar

4 MILLER MC, MAYO KH. Chemokines from a structural perspective. International journal of molecular sciences. 2017;18(10):2088. Search in Google Scholar

5 VAN COILLIE E, VAN DAMME J, OPDENAKKER G. The MCP/eotaxin subfamily of CC chemokines. Cytokine & growth factor reviews. 1999;10(1):61-86. Search in Google Scholar

6 KUNKEL SL. Through the looking glass: the diverse in vivo activities of chemokines. The Journal of clinical investigation. 1999;104(10):1333-4. Search in Google Scholar

7 BRESLIN WL, JOHNSTON CA, STROHACKER K, CARPENTER KC, DAVIDSON TR, MORENO JP, FOREYT JP et al. Obese Mexican American children have elevated MCP-1, TNF-α, monocyte concentration, and dyslipidemia. Pediatrics. 2012;129(5):e1180-6. Search in Google Scholar

8 BUI TM, WIESOLEK HL, SUMAGIN R. ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis. Journal of Leucocyte Biology. 2020;108(3):787-99. Search in Google Scholar

9 STEINMETZ J, SCHIELE F, GUEGUEN R, FÉRARD G, HENNY J; Periodic Health Examination Centers Laboratory Working Group. Standardization of gamma-glutamyltransferase assays by intermethod calibration. Effect on determining common reference limits. Clin Chem Lab Med. 2007;45(10):1373-80. doi: 10.1515/CCLM.2007.290. PMID: 17924850. Search in Google Scholar

10 BEUTLER E, Reduced glutathione (GSH), in Red Cell Metabolism, A Manual of Biochemical Methods, E. Beutler and F. L. Orland, Eds., pp. 131–132, Grune&Stratton, New York, NY, USA, 1975. Search in Google Scholar

11 NAIDU BT, RAJU KS, BHASKARARAO JV, KUMAR NS. Gamma-glutamyl transferase as a diagnostic marker of metabolic syndrome. Cureus. 2023;15(6). Search in Google Scholar

12 BRADLEY R. Gamma glutamyltransferase (GGT) as a biomarker of atherosclerosis. Biomarkers in cardiovascular disease. Biomarkers in disease: methods, discoveries and applications. Springer, Dordrecht. 2016. Search in Google Scholar

13 AHN HR, SHIN MH, NAM HS, PARK KS, LEE YH, JEONG SK, CHOI JS et al. The association between liver enzymes and risk of type 2 diabetes: the Namwon study. Diabetology & metabolic syndrome. 2014;6(1):1-8. Search in Google Scholar

14 NANO J, MUKA T, LIGTHART S, HOFMAN A, DARWISH MURAD S, JANSSEN HL, FRANCO OH et al. Gamma-glutamyltransferase levels, prediabetes and type 2 diabetes: a Mendelian randomization study. International journal of epidemiology. 2017;46(5):1400-7 Search in Google Scholar

15 PENG, JIA, FEI LUO, GUIYUN RUAN, RAN PENG, AND XIANGPING LI. Hypertriglyceridemia and atherosclerosis. Lipids in health and disease 2017;16:1-12. Search in Google Scholar

16 XUAN, CHAO, JING LI, RU-HUA LIU, JUN-JIE GUO, CONG ZHAO, TING-TING ZHOU, YAN WANG, GUO-WEI HE, AND LI-MIN LUN. Association between serum gamma-glutamyltransferase and early-onset coronary artery disease: a retrospective case-control study. Annals of Medicine. 2023; 55(2):2289606 Search in Google Scholar

17 PAOLICCHI A, EMDIN M, PASSINO C, et al. Lipoprotein and LDL-associated serum γ-glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis. 2006;186:80–85. Search in Google Scholar

18 PARK EO, BAE EJ, PARK BH, CHAE SW. The associations between liver enzymes and cardiovascular risk factors in adults with mild dyslipidemia. Journal of clinical medicine. 2020;9(4):1147. Search in Google Scholar

19 BIN DAHMAN LS, HUMAM MA, BARAHIM OH, BARAHMAN OM, BALFAS MA. Association between Liver Enzymes and Dyslipidemia in Yemeni Patients with Type Two Diabetes Mellitus. Journal of Diabetes Mellitus. 2021;11(02):41-51. Search in Google Scholar

20 XING Y, CHEN J, LIU J, MA H. Associations between GGT/HDLC and MAFLD: a cross-sectional study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2022. 383-94. Search in Google Scholar

21 GONG S, GAN S, ZHANG Y, ZHOU H, ZHOU Q. Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio is a more powerful marker than TyG index for predicting metabolic syndrome in patients with type 2 diabetes mellitus. Frontiers in Endocrinology. 2023;14. Search in Google Scholar

22 CHEN LW, HUANG MS, SHYU YC, CHIEN RN. Gamma‐glutamyl transpeptidase elevation is associated with metabolic syndrome, hepatic steatosis, and fibrosis in patients with nonalcoholic fatty liver disease: A community‐based cross‐sectional study. The Kaohsiung Journal of Medical Sciences. 2021;37(9):819-27. Search in Google Scholar

23 DILLON JF, MILLER MH. Gamma glutamyl transferase ‘To be or not to be’ a liver function test? Annals of Clinical Biochemistry.2016;53(6):629-631. Search in Google Scholar

24 JIANG S, JIANG D, TAO Y. Role of gamma-glutamyltransferase in cardiovascular diseases. Experimental & Clinical Cardiology. 2013;18(1):53. Search in Google Scholar

25 IHM CG, PARK JK, HONG SP, LEE TW, CHO BS, KIM MJ, CHA DR, et al. A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells. Nephron. 1998;79(1):33-7. Search in Google Scholar

26 KINOSHITA K, TOSHIKUNI N, SAITO T, HAYASHI N, MINATO T, MATSUE Y, UEDA Y et al. The combination of fatty liver and increased gamma-glutamyl transpeptidase levels as a risk factor for atherosclerotic plaque development in apparently healthy people.Turkish Journal of Medical Sciences. 2019;49(5):1350-7 Search in Google Scholar

27 FRANZINI M, CORTI A, MARTINELLI B, et al. Gamma-glutamyltransferase activity in human atherosclerotic plaques – biochemical similarities with the circulating enzyme. Atherosclerosis. 2009;202(1):119–127 Search in Google Scholar

28 MABILE L, RUIDAVETS J-B, FAUVELJ ; PERRET B, FERRIÈRES J, Differential Levels of γ-Glutamyl Transferase Activity and Apolipoprotein CIII in Men on Either Statin or Fibrate Therapy, Diabetes Care 2003;26(5):1652–1653 Search in Google Scholar

29 OUCHI K.W.N., PARKER J.L., LUGUS J.J., WALSH K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011;11:85–97 Search in Google Scholar

30 KATSIKI N, MIKHAILIDIS DP, BANACH M, Leptin, cardiovascular diseases and type 2 diabetes mellitus review-article. Acta Pharmacol. Sin. 2018, 39, 1176–1188 Search in Google Scholar

31 GOYAL R, FAIZY AF, SIDDIQUI SS, SINGHAI M. Evaluation of TNF-α and IL-6 levels in obese and non-obese diabetics: pre-and postinsulin effects. North American journal of medical sciences. 2012;4(4):180. Search in Google Scholar

32 SHARMA R, SHARMA S, KAUSHIK GG. Gamma-glutamyltransferase (GGT) – a novel marker of endothelial dysfunction. JIACM. 2010;11(1):26–30 Search in Google Scholar

33 ATAY AE, ESEN B, AKBAS H, GOKMEN ES, PILTEN S, GULER H, YAVUZ DG. Polimorfismo 1462A> G (K469E) del gen ICAM-1 y nivel sérico de ICAM-1 en la oligoalbuminuria de pacientes obesos no diabéticos, no hipertensos y normolipidémicos: acervo genético de la oligoalbuminuria en la obesidad. Nefrología (Madrid). 2017;37(4):381-8. Search in Google Scholar

34 ADAMIEC-MROCZEK J, OFICJALSKA-MŁYŃCZAK J, MISIUK-HOJŁO M. Proliferative diabetic retinopathy—The influence of diabetes control on the activation of the intraocular molecule system. Diabetes research and clinical practice. 2009;84(1):46-50. Search in Google Scholar

35 BRADLEY R, FITZPATRICK AL, JENNY NS, LEE DH, JACOBS DR Jr. Associations between total serum GGT activity and metabolic risk: MESA. Biomark Med. 2013;7(5):709-21 Search in Google Scholar